ATYR
aTyr Pharma
ATYR
ATYR
46 hedge funds and large institutions have $58.2M invested in aTyr Pharma in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.08% more ownership
Funds ownership: 64.35% → 70.43% (+6.1%)
1% less capital invested
Capital invested by funds: $58.7M → $58.2M (-$521K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
46
Holding in Top 10
–
Calls
$3K
Puts
$1K
Top Buyers
| 1 | +$8.25M | |
| 2 | +$525K | |
| 3 | +$335K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$320K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$210K |
Top Sellers
| 1 | -$5.84M | |
| 2 | -$666K | |
| 3 | -$133K | |
| 4 |
Two Sigma Investments
New York
|
-$92.8K |
| 5 |
Two Sigma Advisers
New York
|
-$58.5K |